德国心脏CT注册研究中1097例非冠状动脉心脏CTA的系统报告
该研究前瞻性分析德国心脏CT注册研究中1097例因非冠状动脉临床指征行心脏CTA的患者,评估其当代适应证、安全性和诊断影响。最常见指征为肺静脉解剖评估(65.9%),非冠状动脉心脏CTA并发症率很低(1.5%),平均有效剂量5.2 mSv,并在3.2%患者中揭示新的临床诊断方面。
要点
- 非冠状动脉心脏CTA最常见指征为肺静脉解剖评估(65.9%,723/1097),其次为TAVI术前规划(44.5%,69/155)。
- 前瞻性心电触发采集最常用(74.0%),平均估计有效剂量5.2 mSv(IQR 2.9-9.5 mSv)。
- 总体并发症率很低(1.5%),非冠状动脉心脏CTA在3.2%患者中揭示新临床诊断方面,2.2%揭示新主要临床诊断。
核心结论
- 非冠状动脉心脏CTA作为常规诊断手段,使用当代CT系统时并发症率很低且辐射暴露合理偏低。
研究设计与样本
- 前瞻性分析德国心脏CT注册研究中2009至2014年间连续1097例因临床非冠状动脉指征行心脏CTA的患者数据。
- 使用64排或更新CT系统,来自德国十二家三级心脏中心,所有中心以预定义模板电子提交患者和检查数据。
诊断标准与关键数值
- 最常见非冠状动脉指征为肺静脉解剖评估,占65.9%(723/1097)。
- 其余病例中最常见指征为TAVI术前规划(44.5%,69/155)、瓣膜病评估(31.6%,49/155)和植入物评估(5.8%,9/155)。
- 非冠状动脉心脏CTA中位碘对比剂用量为100.0 mL(IQR 95.0-110.0 mL)。
- 前瞻性心电触发采集最常用(74.0%),其次为回顾性心电门控采集伴和不伴管电流调制(分别为19.9%和6.0%)。
- 平均估计有效剂量为5.2 mSv(IQR 2.9-9.5 mSv,平均转换因子k=0.026)。
临床应用与阅片要点
- 非冠状动脉心脏CTA总体并发症率很低(1.5%)。
- 非冠状动脉心脏CTA在所有患者中3.2%揭示新临床诊断方面,2.2%揭示新主要临床诊断。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To prospectively evaluate contemporary indications, safety and diagnostic impact of cardiac CTA in patients undergoing cardiac CTA examinations for non-coronary clinical indications.
METHOD: We analyzed 1097 consecutive patients from the German Cardiac CT Registry who underwent cardiac CTA between 2009 and 2014 due to clinically indicated non-coronary reasons using 64-slice or newer CT systems in twelve tertiary German heart centers in order to evaluate the impact of clinical indications on procedure-associated parameters. All participating centers electronically submitted patient and examination data including detailed indications, clinical symptoms, procedural parameters, complications and diagnostic results in a predefined template.
RESULTS: The most frequent indication for non-coronary cardiac CTA was the evaluation of pulmonary vein anatomy (65.9 %, 723/1097). In the remaining cases, most frequent indications were planning before TAVI (44.5 %, 69/155), evaluation of valvular disease (31.6 %, 49/155), and evaluation of implants (5.8 %, 9/155). Non-coronary cardiac CTA required a median amount of iodinated contrast agent of 100.0 mL (IQR 95.0-110.0 mL). Prospectively ECG-triggered acquisition was the most frequently used protocol (74.0 %), followed by retrospectively ECG-gated acquisition with and without tube current modulation (19.9 % and 6.0 %, respectively), resulting in a mean estimated effective dose of 5.2 mSv (IQR 2.9-9.5 mSv, average conversion factor k = 0.026). Overall, complication rate was very low (1.5 %). Non-coronary cardiac CTA revealed a new clinical diagnostic aspect in 3.2 % of all patients, and a new main clinical diagnosis in 2.2 %.
CONCLUSIONS: Non-coronary cardiac CTA as a routinely applied diagnostic modality is associated with a very low procedure-related rate of complications and reasonably low radiation exposure using contemporary CT systems.
引用
- Gitsioudis G, Marwan M, Schneider S, et al. A systematic report on non-coronary cardiac CTA in 1097 patients from the German cardiac CT registry. Eur J Radiol. 2020. PMID: 32634756. doi:10.1016/j.ejrad.2020.109136
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。